180 related articles for article (PubMed ID: 7738032)
1. Calpains are activated in necrotic fibers from mdx dystrophic mice.
Spencer MJ; Croall DE; Tidball JG
J Biol Chem; 1995 May; 270(18):10909-14. PubMed ID: 7738032
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology.
Spencer MJ; Mellgren RL
Hum Mol Genet; 2002 Oct; 11(21):2645-55. PubMed ID: 12354790
[TBL] [Abstract][Full Text] [Related]
3. Calpain concentration is elevated although net calcium-dependent proteolysis is suppressed in dystrophin-deficient muscle.
Spencer MJ; Tidball JG
Exp Cell Res; 1992 Nov; 203(1):107-14. PubMed ID: 1426033
[TBL] [Abstract][Full Text] [Related]
4. Calpain translocation during muscle fiber necrosis and regeneration in dystrophin-deficient mice.
Spencer MJ; Tidball JG
Exp Cell Res; 1996 Aug; 226(2):264-72. PubMed ID: 8806430
[TBL] [Abstract][Full Text] [Related]
5. PDGF-receptor concentration is elevated in regenerative muscle fibers in dystrophin-deficient muscle.
Tidball JG; Spencer MJ; St Pierre BA
Exp Cell Res; 1992 Nov; 203(1):141-9. PubMed ID: 1426037
[TBL] [Abstract][Full Text] [Related]
6. In situ measurements of calpain activity in isolated muscle fibres from normal and dystrophin-lacking mdx mice.
Gailly P; De Backer F; Van Schoor M; Gillis JM
J Physiol; 2007 Aug; 582(Pt 3):1261-75. PubMed ID: 17510188
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of Dp427-deficient mdx tissues shows that the milder dystrophic phenotype of extraocular and toe muscle fibres is associated with a persistent expression of beta-dystroglycan.
Dowling P; Lohan J; Ohlendieck K
Eur J Cell Biol; 2003 May; 82(5):222-30. PubMed ID: 12800977
[TBL] [Abstract][Full Text] [Related]
8. Modifications in myotendinous junction surface morphology in dystrophin-deficient mouse muscle.
Ridge JC; Tidball JG; Ahl K; Law DJ; Rickoll WL
Exp Mol Pathol; 1994 Aug; 61(1):58-68. PubMed ID: 7995379
[TBL] [Abstract][Full Text] [Related]
9. Proteolysis results in altered leak channel kinetics and elevated free calcium in mdx muscle.
Turner PR; Schultz R; Ganguly B; Steinhardt RA
J Membr Biol; 1993 May; 133(3):243-51. PubMed ID: 8392585
[TBL] [Abstract][Full Text] [Related]
10. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
[TBL] [Abstract][Full Text] [Related]
11. Identification of mu-, m-calpains and calpastatin and capture of mu-calpain activation in endothelial cells.
Fujitani K; Kambayashi J; Sakon M; Ohmi SI; Kawashima S; Yukawa M; Yano Y; Miyoshi H; Ikeda M; Shinoki N; Monden M
J Cell Biochem; 1997 Aug; 66(2):197-209. PubMed ID: 9213221
[TBL] [Abstract][Full Text] [Related]
12. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.
Guo Y; Petrof BJ; Hussain SN
Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948
[TBL] [Abstract][Full Text] [Related]
13. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
Montgomery E; Pennington C; Isales CM; Hamrick MW
Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
[TBL] [Abstract][Full Text] [Related]
14. Effect of calpain and proteasome inhibition on Ca2+-dependent proteolysis and muscle histopathology in the mdx mouse.
Briguet A; Erb M; Courdier-Fruh I; Barzaghi P; Santos G; Herzner H; Lescop C; Siendt H; Henneboehle M; Weyermann P; Magyar JP; Dubach-Powell J; Metz G; Meier T
FASEB J; 2008 Dec; 22(12):4190-200. PubMed ID: 18728218
[TBL] [Abstract][Full Text] [Related]
15. Subproteomics analysis of Ca+-binding proteins demonstrates decreased calsequestrin expression in dystrophic mouse skeletal muscle.
Doran P; Dowling P; Lohan J; McDonnell K; Poetsch S; Ohlendieck K
Eur J Biochem; 2004 Oct; 271(19):3943-52. PubMed ID: 15373840
[TBL] [Abstract][Full Text] [Related]
16. Enhancing Endogenous Nitric Oxide by Whole Body Periodic Acceleration Elicits Neuroprotective Effects in Dystrophic Neurons.
Lopez JR; Uryash A; Kolster J; Estève E; Zhang R; Adams JA
Mol Neurobiol; 2018 Nov; 55(11):8680-8694. PubMed ID: 29582400
[TBL] [Abstract][Full Text] [Related]
17. Expression rate of myogenic regulatory factors and muscle growth factor after botulinum toxin A injection in the right masseter muscle of dystrophin deficient (mdx) mice.
Botzenhart UU; Gerlach R; Gredes T; Rentzsch I; Gedrange T; Kunert-Keil C
Adv Clin Exp Med; 2019 Jan; 28(1):11-18. PubMed ID: 30085421
[TBL] [Abstract][Full Text] [Related]
18. Transient receptor potential cation channels in normal and dystrophic mdx muscle.
Krüger J; Kunert-Keil C; Bisping F; Brinkmeier H
Neuromuscul Disord; 2008 Jun; 18(6):501-13. PubMed ID: 18504127
[TBL] [Abstract][Full Text] [Related]
19. Myotonic ADR-MDX mutant mice show less severe muscular dystrophy than MDX mice.
Krämer R; Lochmüller H; Abicht A; Rüdel R; Brinkmeier H
Neuromuscul Disord; 1998 Dec; 8(8):542-50. PubMed ID: 10093060
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of regucalcin in young and aged mdx diaphragm indicates abnormal cytosolic calcium handling in dystrophin-deficient muscle.
Doran P; Dowling P; Donoghue P; Buffini M; Ohlendieck K
Biochim Biophys Acta; 2006 Apr; 1764(4):773-85. PubMed ID: 16483859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
